Bank of Nova Scotia
NVO

Bank of Nova Scotia’s Novo Nordisk NVO Stock Holding History

Bank of Nova Scotia’s Portfolio NVO Stock Details NVO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		– Sell
-260
Closed -$13.2K – 1171
2025
Q4 		$13.2K Hold
260
– – ﹤0.01% 1100
2025
Q3 		$14.4K Buy
+260
New +$15.2K ﹤0.01% 1043

Other funds holding NVO

Dodge & Cox
Dodge & Cox San Francisco, California $182B AUM 14.68% 1-Year Est. Return
Loomis, Sayles & Company
Loomis, Sayles & Company Boston, Massachusetts $74.3B AUM 24.01% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return
Capital International Investors
Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return
Susquehanna International Group
Susquehanna International Group Bala Cynwyd, Pennsylvania $893B AUM 36.07% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
DAM
Diamant Asset Management Ridgefield, Connecticut $147M AUM 25.76% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return
F
Folketrygdfondet Oslo Norway, Norway $5.64B AUM 47.16% 1-Year Est. Return

Bank of Nova Scotia's NVO Position: Q1 2026 in Review

Bank of Nova Scotia increased its Novo Nordisk (NVO) stake by 8.9% in Q1 2026, buying an estimated $210K and bringing the position to 54,407 shares worth $2M. The position accounts for ﹤0.01% of the portfolio, ranked #747.

Bank of Nova Scotia first reported a position in NVO in Q1 2016 and has held it in 10 quarters since. The position peaked at $9.75M in Q1 2016. 1,276 funds tracked by Wall St. Rank hold NVO as of Q1 2026.

  • Bank of Nova Scotia held 54,407 shares of Novo Nordisk worth $2M as of Q1 2026.
  • Bank of Nova Scotia bought 4,440 Novo Nordisk shares in Q1 2026, an estimated $210K.
  • Novo Nordisk made up ﹤0.01% of Bank of Nova Scotia's portfolio in Q1 2026, its #747 holding.
  • Bank of Nova Scotia first reported a position in Novo Nordisk in Q1 2016 and has held it in 10 quarters since.
  • Bank of Nova Scotia's Novo Nordisk position peaked at $9.75M in Q1 2016.
  • 1,276 funds tracked by Wall St. Rank held Novo Nordisk as of Q1 2026.

Based on Bank of Nova Scotia's 13F filing for Q1 2026, filed 14 May 2026.